Introduction

Dual-layer spectral computed tomography (DLSCT) is a novel computed (CT) platform of dual-energy computed tomography (DECT) in which 2 sets of attenuating data are acquired from specialized layered detectors. This new technique enhanced diagnostic performance in head and neck cancer as compared to conventional single-energy computed tomography (SECT) [1-6]. Virtual non-contrast (VNC) imaging is one of the promising applications of DLSCT which subtract iodine attenuation from post-contrast data and generate imaging theoretically resembling true non-contrast (TNC) imaging [1-6].

The CT scan is a useful diagnostic tool for staging and treatment planning in upper aerodigestive tract cancer (UATC) [1-3]. In routine conventional SECT, the protocol for UATC typically requires true non-contrast (TNC) imaging and post-contrast imaging in order to characte-rize tumour and lymph node enhancement.

This study aimed to qualitatively and quantitatively compare the attenuation values and the image quality of TNC and VNC datasets in patients with UATC, and to evaluate the potential radiation dose reduction by waiving the TNC phase.

Material and methods

Study population

The study was approved by the Human Ethics Committee of our institution. We retrospectively reviewed the me-dical records of patients with UATC at Thammasat University Hospital, Thailand, from January 2020 to November 2021.

The inclusion criteria were as follows: 1) patients who were 18 years old or above; 2) patients who had histopathologically confirmed UATC; 3) patients who underwent pre-treatment DLSCT. The exclusion criterion was patients who had severe imaging artifacts on CT scans.

Sixty-one consecutive patients were included in this study. Demographic data including age, sex, underlying disease, and an indication of the CT scan were collected from the medical records. The histopathological results were acquired from the pathological reports.

Imaging acquisition

All scans were performed using a dual-layer spectral CT scanner (Philips IQon Spectral CT and Spectral CT7500, Philips Healthcare, Eindhoven, Netherlands). All patients underwent a standard CT protocol of the institute, which included pre-contrast (true non-contrast, TNC) and post-contrast phases. Patients were placed in a supine position. All scans were performed with a 120 kVp tube voltage, 1.4:1 helical pitch, and 0.4-second rotation time with a reconstructed FOV of 512 mm2. Automated mAS and beam collimation were applied and varied according to patient thickness. The detector configurations were 64 × 0.625 mm and 128 × 0.625 mm for Philips IQon Spectral CT and Spectral CT7500, respectively.

After an anteroposterior scout, TNC phase was scanned from skull base to aortic arch in the cranio-caudal direction. Subsequently, a weight adapted amount (1.5 mL/kg) of non-ionic iodinated contrast agent (Ultravist 300 MCT, Bayer Vital GmbH, Leverkusen, Germany) followed by a 30-mL saline chaser was injected intravenously with a rate of 2.5 mL/sec using a dual syringe injection system (Stellant, MEDRAD, Indianola, Pennsylvania). The post-contrast phase was acquired at 70 seconds after contrast administration in the same field of view and scan direction as performed on TNC. All datasets were reconstructed in the axial images by using a section thickness and an interval of 3.5 mm.

Imaging post-processing

The raw data were reconstructed using a specific spectral post-processing workstation (IntelliSpace Portal v.11, Philips Healthcare, Netherlands). The VNC images were obtained from post-contrast images using vendor-specific software (Figure 1). Axial TNC and VNC images were reconstructed using a section thickness and an interval of 3.5 mm.

Figure 1

A 78-year-old woman with CA soft palate. A) Axial true noncontrast image was performed before intravenous contrast administration. B) Axial contrast-enhanced image was performed after intravenous contrast administration 70 seconds. C) Axial virtual non-contrast image was reconstructed due to iodine subtraction from the contrast-enhanced image by using postprocessing algorithms

https://www.polradiol.com/f/fulltexts/152665/PJR-87-49802-g001_min.jpg

Imaging assessment

For all CT images, quantitative analysis and qualitative assessment were retrospectively evaluated using a picture archiving and communications system (PACS) for CT attenuation value, imaging noise, and imaging quality. CT images were reviewed by 2 observers, a neuroradiologist with 10 years of experience and a third-year resident. Both observers were unaware of imaging acquisition. The location of each ROI and image quality of TNC and VNC images were obtained by consensus.

CT attenuation values of the tumour (Figure 2) and 4 other normal ipsilateral anatomic structures including the buccal fat pad, tonsillar region, sternocleidomastoid muscle, and medial pterygoid muscle were measured by placing regions of interests (ROIs) (Figure 3). Each of the ROIs was placed at the same imaging level and location in TNC and VNC images. VNC images were compared to TNC images regarding differences in CT attenuation values.

Figure 2

A 44-year-old woman with CA soft palate. Comparison of computed tomography attenuation values of the tumor at the same level between (A) axial true non-contrast image – 40.3 HU and (B) axial virtual noncontrast image – 39.3 HU

https://www.polradiol.com/f/fulltexts/152665/PJR-87-49802-g002_min.jpg
Figure 3

A 84-year-old man with CA supraglottic. Comparison of computed tomography attenuation values of the buccal fat pad (A), tonsillar region (B), medial pterygoid muscle (C), and sternocleidomastoid muscle (D) between axial true non-contrast images (upper row of figure) and axial virtual noncontrast images (lower row of figure) at the same level

https://www.polradiol.com/f/fulltexts/152665/PJR-87-49802-g003_min.jpg

The standard deviations (SD) of the pixel value of subcutaneous fat at the anterior neck acquired from ROI placement was used to determine the imaging noise (Figure 4).

Figure 4

A 84-year-old man with CA supraglottic (the same patient as in Figure 3). To determine the imaging noise, the standard deviations (SD) of anterior subcutaneous fat of the neck were measured between (A) axial true non-contrast images – SD = 11.9 and (B) axial virtual non-contrast images – SD = 12.0 at the same level

https://www.polradiol.com/f/fulltexts/152665/PJR-87-49802-g004_min.jpg

Therefore, a total of 6 ROIs (one tumour, 4 anatomic regions, and one noise subsite) were placed per TNC and VNC for individual subjects. The minimum area of individual ROI was at least 20 mm2.

The subjective image quality was assessed by using a 5-point grade scale scoring system, which is the same method as in previous literature: 1 = not assessable due to severe artifacts or bad image quality; 2 = poor image quality from major artifacts; 3 = sufficient image quality that permits good confidence in image evaluation; 4 = good image quality with minor artifacts; 5 = excellent image quality without artifacts [4] (Figure 5). The level of acceptance for diagnosis purposes with VNC images was rated as 3. A score of 4 or more was considered as having the potential to replace TNC images.

Figure 5

Image quality evaluation in different patients between axial TNC images (upper row of figure) and axial VNC images (lower row of figure) at the same level. A) IQ score=3; sufficient image quality with moderate artifacts in both images, (B) IQ score=4; good image quality with minor artifacts in both images, (C) IQ score=5; excellent image quality without artifacts in both images

https://www.polradiol.com/f/fulltexts/152665/PJR-87-49802-g005_min.jpg

Radiation dose estimation

For each of the 2 phases, the dose-length product (DLP, mGy cm) was recorded from registered data using a CT scanner. The effective radiation doses (in millisieverts) for each phase were calculated by using the method proposed by the European Working Group for Guidelines on Quality criteria in CT, applying the following relationship: E = DLP × k conversion coefficient. The neck k conversion coefficient is 0.0054 mSv/mGy cm [5-7]. The effective dose of a biphasic TNC and post-contrast CT protocol was compared with a single-phase protocol (post-contrast CT with VNC reconstruction). The percentage of potential dose reduction by omitting TNC was calculated.

Statistical analysis

CT attenuation value, imaging noise, and quality on TNC and VNC images were interpreted in terms of the mean ± standard deviation. Mean differences in CT attenuation values, imaging noises, and quality between TNC and VNC images were compared using the paired t-test. Fisher’s exact test was used for categorization of the image quality scores. The radiation dose of conventional biphasic TNC-post contrast protocol and a single post-contrast protocol with VNC reconstruction were analysed in terms of the mean ± standard deviation. Radiation dose reduction between the 2 protocols was expressed in percent ± standard deviation. All statistical analysis was performed by using statistical software software (R version 4.1.1, R Foundation for Statistical Computing, Vienna, Austria). A value of p < 0.05 indicated a statistically significant difference.

Results

Demographics

There were 61 consecutive patients included in this study; 47 patients were males and 14 patients were females. The mean age at diagnosis was 63.5±12.8 years (age range 35-91 years). All patients had histopathological results of upper aerodigestive tract cancer in various locations (nasal cavity and paranasal sinuses, n = 4; nasopharynx, n = 5; oropharynx, n = 8; hypopharynx, n = 7; oral cavity, n = 17; larynx, n = 20). Details of patients’ demographic data are summarized in Table 1.

Table 1

Patient demographics (N = 61)

Factor
Age, years
Mean (SD)63.5 (12.8)
Range35-91
Gender, n (%)
Male47 (77)
Female14 (23)
Location, n (%)
Nasal cavity and paranasal sinuses4 (6.6)
Nasopharynx5 (8.2)
Oropharynx8 (13.1)
Hypopharynx7 (11.5)
Oral cavity17 (27.9)
Larynx20 (32.8)
Histopathological result, n (%)
Squamous cell carcinoma59 (96.72)
Adenoid cystic carcinoma1 (1.64)
Neuroendocrine carcinoma1 (1.64)

CT attenuation values

There was no statistical difference in the mean CT attenuation values between TNC and VNC images for tumour and all tissue types, except for the buccal fat pad. The mean CT attenuation values of all tissue types were as follows: tumour; 43.6 ± 6.5 HU on TNC and 44.0 ± 6.8 HU on VNC (p = 0.3969), buccal fat pad; –89.2 ± 14.6 HU on TNC and –88.5 ± 14.5 HU on VNC (p = 0.0074), tonsillar region; 45.9 ± 6.3 HU on TNC and 46.2 ± 5.4 HU on VNC (p = 0.4401), medial pterygoid muscle; 60.4 ± 5.8 HU on TNC and 60.1 ± 5.8 HU on VNC (p = 0.0919), and sternocleidomastoid muscle; 55.2 ± 6.1 HU on TNC and 54.7 ± 6.0 HU on VNC (p = 0.3593). The greatest differences between TNC and VNC images were detected in buccal fat pad (–0.7 ± 2.0). Mean CT attenuation values and p-values are presented in Table 2.

Table 2

Mean computed tomography attenuation values, imaging noise, and p-values between true non-contrast and virtual non-contrast images

CT attenuation value (HU)TNC Mean (SD)VNC Mean (SD)Difference Mean (SD)Difference > 10 HU n (%)p-value
Tumour43.6 (6.5)44 (6.8)–0.4 (3.3)2 (3.3)0.3969
Buccal fat pad–89.2 (14.6)–88.5 (14.5)–0.7 (2)1 (1.6)0.0073
Tonsillar region45.9 (6.3)46.2 (5.4)–0.3 (3.1)1 (1.6)0.4401
Medial pterygoid muscle60.4 (5.8)60.1 (5.8)0.3 (1.3)0 (0)0.0919
Sternocleidomastoid muscle55.2 (6.1)54.7 (6)0.5 (4.3)5 (8.2)0.3593
Noise8.8 (2.5)8.7 (2.5)0.1 (1.4)0 (0)0.5455

* Statistically significant at p-value < 0.05 determined by the paired t-test

In all tissue types, the difference in mean CT attenuation values between TNC and VNC images was less than 15 HU (Figure 6).

Figure 6

Box-and-whisker plots of the differences in HU between the true non-contrast and virtual non-contrast images. The box indicates the 25th and 75th quartile; the horizontal line indicates the median and the cross indicates the mean. Whiskers show the 5th and 95th percentiles; outliers are performed by the circles

https://www.polradiol.com/f/fulltexts/152665/PJR-87-49802-g006_min.jpg

Overall, 97% of all scans had a difference in mean CT attenuation values less than 10 HU. The difference of mean CT attenuation values between TNC and VNC images was less than 10 HU in 96.7%, 98.4%, 98.4%, and 91.8% of the tumour, buccal fat pad, tonsillar region, and sternocleidomastoid muscle, respectively. There was no difference in mean CT attenuation values greater than 10 HU of medial pterygoid muscle between TNC and VNC images. The frequency of cases with absolute diffe-rences in mean CT attenuation less than 10 HU is shown in Figure 7.

Figure 7

Differences in computed tomography attenuation values < 10 HU between the true non-contrast and virtual non-contrast images

https://www.polradiol.com/f/fulltexts/152665/PJR-87-49802-g007_min.jpg

Imaging noise

The mean SD for imaging noise was 8.8 ± 2.5 and 8.7 ± 2.5 in TNC and VNC, respectively. There was no significant difference in imaging noise between TNC and VNC (p = 0.5455) (Table 2).

In total, there were 732 ROIs acquired from 5 different tissues and one noise from 61 patients in 2 datasets (TNC and VNC).

Image quality

By using a 5-point grading system, the image quality was rated as excellent quality (score 5) in 47 (77%) and 49 (80.3%) of TNC and VNC studies, respectively. There were 4 (6.6%) TNC studies and 2 (3.3%) VNC studies assessed as good quality (score 4). Both TNC and VNC were rated as sufficient quality (score 3) in 10 (16.4%) and 10 (16.4%) of the TNC and VNC studies, respectively. None of the studies was rated below the score of 3. Image quality of TNC and VNC images had average scores of 4.61 ± 0.76 and 4.64 ± 0.75, respectively. There was no significant difference of image quality between TNC and VNC (p = 0.159) (Table 3).

Table 3

Image quality between true non-contrast and virtual non-contrast images

Image qualityTNC n (%)VNC n (%)p-value
1 (not assessable)000.159
2 (poor)00
3 (sufficient)10 (16.4)10 (16.4)
4 (good)4 (6.6)2 (3.3)
5 (excellent)47 (77.0)49 (80.3)
Mean (SD)4.61 (0.76)4.64 (0.75)

Radiation dose

The mean effective radiation doses for the TNC and post-contrast scan were 2.6 ± 1.7 mSv and 2.6 ± 1.8 mSv, respectively. For the combined biphasic TNC and post-contrast CT protocol, the total mean effective dose was 5.2 ± 3.4 mSv. To summarize, the percentage of potential dose reduction by omitting the conventional unenhanced CT scan was 49.5 ± 3.5% (Table 4).

Table 4

Effective radiation dose in 2-phase protocol and dose reduction by omitting the conventional unenhanced computed tomography scan

Pre-contrast phasePost-contrast phasePre- and post-contrast phasesRadiation dose reduction (%)
DLP (mGy-cm)
Mean (SD)474.7 (307.9)486.2 (327.7)960.9 (631.6)49.5 (3.5)
ED (mSv)
Mean (SD)2.6 (1.7)2.6 (1.8)5.2 (3.4)49.5 (3.5)

Discussion

VNC imaging is one of the promising capabilities of DECT that can provide imaging theoretically resembling TNC images from an iodine elimination technique, which is performed on a material decomposition basis [8-13]. DLSCT is a novel technique of DECT, generating imaging from a specialized layered CT detector [2,7, 14-18]. One of the major advantages of DLSCT over other techniques of DECT – dual-source DECT and rapid kilovolt peak (kVp) switching DECT – is that DLSCT is always on dual-energy mode with availability of retrospective analysis for every scan. Thus, there is no need for pre-planning and pre-selection of the dual-energy mode in DSLCT [13,15,19].

CT scan of the neck is an essential imaging modality for UATC in pre-treatment staging and treatment planning. Routine protocol of CT neck in UATC typically requires a biphasic TNC and post-contrast CT protocol aiming to characterize the enhancing pattern of the tumour. A single-phase protocol (post-contrast CT with VNC reconstruction) available from DSLCT has advantages over conventional biphasic TNC protocol owing to decreased examination time and radiation dose [2,20].

There have been several previous studies that mainly researched the clinical feasibility of using VNC images in abdominal imaging from various DECT systems, including detecting aortic endoleak after endovascular repair, urinary or biliary stones, intracranial bleeding, mediastinal lymph nodes, and characterizing masses such as renal, solitary pulmonary nodule, hepatic, pancreas, and gastric masses [21-30]. Most of them revealed that VNC images were useful and feasible. Sauter et al. studied VNC acquired from DLSCT in abdominal imaging and found that VNC imaging is a promising tool for clinical usage with radiation dose reduction and enhanced diagnostic value of a single-phase post-contrast CT [23]. Similar results were reported by Mileto et al., who worked on VNC generated from dual-source DECT in pancreatic imaging [27]. They found that VNC had no significant difference in image quality but lower imaging noise and radiation dose compared to TNC. Shi et al. also concluded that VNC can potentially replace TNC in evaluation of gastric tumours by using dual-source DECT [25]. Meyer et al. also reported strong correlation between VNC and TNC for characterization of renal lesions. However, VNC had lower diagnostic performance for depicting contrast-enhanced versus nonenhanced renal lesions as compared to TNC [24].

On the other hand, a few studies reported different results. Durieux et al. concluded that VNC images created from third-generation dual-source DECT still should not replace TNC images because of substantial differences in attenuation measurements [21]. Similar results were also reported by Lehti et al., who studied VNC based on arterial phase CT angiography acquired from dual-source DECT. They found that VNC had a significantly different mean attenuation value and higher imaging noise as compared to TNC [22].

There were limited publications regarding VNC images in head and neck imaging. Beland et al. found that VNC acquired from rapid kilovolt peak (kVp) switching DECT could eliminate TNC in the diagnosis of sialolithiasis in the major salivary gland [31]. Studies by Fu et al. on VNC imaging for several diseases of cervical lymph nodes concluded that VNC in conjunction with post-contrast imaging provided clear images in the diagnosis of enlarged cervical lymph nodes [32]. However, they did not mention the DECT system used in the study.

To our knowledge, there has been no previous comparative study between VNC and TNC generated from DLSCT in patients with UATC.

CT attenuation values, imaging noise, and imaging quality are the key issues regarding potential replacement of TNC by VNC images [4,20-30,32,33].

This study showed no statistical difference in the mean CT attenuation values between TNC and VNC images for UATC and other tissues (tonsillar region, medial pterygoid muscle, and sternocleidomastoid muscle), except for buccal fat pad (p = 0.007). The significant difference in the CT attenuation value of buccal fat was due to the high variability of attenuation from the ROI measurement on both TNC and VNC for unknown reasons. For buccal fat pad, VNC images had a slightly higher mean CT attenuation value (–88.5 ± 14.5) than for TNC (–89.2 ± 14.6). However, there was only one study that showed a difference in mean CT attenuation value greater than 10 HU for buccal fat. Similar results were described by Sauter et al., who found a difference in abdominal fat CT value between TNC and VNC [23]. Because fat is a tissue with relatively little contrast enhancement, there should be a minimal amount of iodine to be subtracted, so the exact explanation for this difference between TNC and VNC images is still unsolved [23].

According to the results of previous studies, VNC images in which the difference in CT attenuation values was lower than 15 HU were considered relevant in most clinical situations [23]. Our results showed no difference of CT attenuation values greater than 15 HU in all tissue types. Furthermore, 97% of all images had a difference of less than 10 HU between TNC and VNC images. Therefore, VNC images of the neck have potential value for clinical usage.

We used image noise as a representative parameter for the quantitative image quality [34]. Our results showed no statistical difference between TNC and VNC images regarding imaging noise. However, VNC images had slightly lower mean imaging noise than TNC images. This is due to the rendering algorithm in the post-processing technique, creating a smoother image [20,25,34].

In our experience, there was no significant difference in subjective image quality between TNC and VNC images. VNC images had slightly higher average scores of image quality than TNC images. All VNC images were rated as score 3 or more, which is acceptable quality for diagnostic purposes. The VNC images were good quality and were nearly equivalent to TNC images.

The possibility of removing TNC has the benefits of reduced examination time and decreased risk of radiationinduced malignancies, particularly thyroid cancer, because the thyroid is a radiosensitive organ [3,27]. This study demonstrated 49.5 ± 3.5% reduction of radiation dose by omitting TNC.

The present study had some limitations. First, we presented a qualitative and quantitative comparison of TNC and VNC datasets but did not show the accuracy for tumour staging in UATC. However, we assumed that the accuracy for tumour staging on VNC images should be similar on TNC images because there was no significant difference in CT attenuation values between these acquisitions. Second, CT attenuation values in the metastatic cervical nodes could not be evaluated because the accurate discrimination between benign and metastasis by histopathological result for individual lymph nodes was unavailable in this retrospective study. Third, we did not study CT attenuation of the thyroid gland, which has natural intrinsic iodine content and might have different iodine subtraction results from other structures. These should be interesting issues to inspect in the future. Finally, this study was performed using only DSLCT while other DECT systems were unavailable for comparison. Because various DECT systems are limited in most institutions, further multi-centre studies would be challenging.

Conclusions

In our experience, the VNC images were obtained from postprocessing algorithms of the DSLCT. These results confirmed that VNC images provide qualitative and quantitative datasets of good image quality, similar to TNC images. Thus, VNC images are a feasible alternative for implementation in patients with UATC, with the advantage of radiation dose reduction by waiving the TNC phase.